Completed PHASE4 INTERVENTIONAL 2-arm NCT03849729

Effectiveness and Tolerability of Phentermine in Patients Under Bariatric Surgery

Effectiveness and Tolerability of Phentermine in the Reduction of Intrahepatic Fat Infiltration, Adipose Tissue and Postoperative Complications in Patients Under Bariatric Surgery

Sponsor: Hospital Juarez de Mexico

Conditions Bariatric Surgery Morbid Obesity Non-alcoholic Fatty Liver Obesity Weight Loss

Interventions Phentermine Placebo

Updated 6 times since 2019 Last updated: Jul 27, 2020 Started: Mar 1, 2018 Primary completion: Apr 1, 2020 Completion: Apr 1, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Bariatric Surgery and Morbid Obesity and is currently completed. Hospital Juarez de Mexico leads this study, which shows 6 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Aug 2020 — Jan 2021 [monthly]

Completed PHASE4

Status: Recruiting → Completed

▶ Show 1 earlier version

Mar 2019 — Aug 2020 [monthly]

Recruiting PHASE4

First recorded

Mar 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Juarez de Mexico

Data source: Hospital Juarez de Mexico

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mexico City, Mexico